IMAAGEN: Phase 2 trial of abiraterone acetate plus prednisone for advanced prostate cancer | Dr Neal Shore at Annual Meeting 2015

IMAAGEN: Phase 2 trial of abiraterone acetate plus prednisone for advanced prostate cancer | Dr Neal Shore at Annual Meeting 2015

EMJ

4 years
1,011 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Neal Shore, MD, FACS, of Atlantic Urology Clinics, Myrtle Beach, SC, provides an update on IMAAGEN, a multicentre, open-label, single-arm, phase 2 trial evaluating the effect of abiraterone acetate plus prednisone on prostate specific antigen and radiographic disease progression in patients with non-metastatic castration-resistant prostate cancer without radiographic evidence of metastatic disease. European Medical Journal Website: http://emjreviews.com/ Twitter: https://twitter.com/EMJReviews Facebook: https://www.facebook.com/emjreviews
Up Next Autoplay